Skin adnexal carcinomas DNA genomic profiling uncovers oncogenic pathways and potential therapeutic targets

• B. Louveau,
• I. Nakouri,
• F. Jouenne,
• B. Baroudjian,
• A. Sadoux,
• L. Da Meda,
• A. Osio,
• F. Reinhart,
• J. Robert,
• M. Mancini,
• F. Herms,
• B. Cribier,
• L. Mortier,
• T. Jouary,
• N. Basset-Seguin,
• C. Lebbé,
• S. Mourah,
• M. Battistella

Affiliations

B. Louveau

Assistance Publique - Hopitaux de Paris, Hopital Saint-Louis, Department of Pharmacology and Tumor Genomics, Paris, France; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France

I. Nakouri

Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France; Assistance Publique - Hopitaux de Paris, Hopital Saint Louis, Department of Dermatology, Paris, France

F. Jouenne

Assistance Publique - Hopitaux de Paris, Hopital Saint-Louis, Department of Pharmacology and Tumor Genomics, Paris, France; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France

B. Baroudjian

Assistance Publique - Hopitaux de Paris, Hopital Saint Louis, Department of Dermatology, Paris, France

A. Sadoux

Assistance Publique - Hopitaux de Paris, Hopital Saint-Louis, Department of Pharmacology and Tumor Genomics, Paris, France

L. Da Meda

Assistance Publique - Hopitaux de Paris, Hopital Saint Louis, Department of Dermatology, Paris, France

A. Osio

French Network of Rare Skin Cancers, CARADERM, Paris, France; CND-Paris la Roquette, Ivry, France; Assistance Publique - Hopitaux de Paris, Hopital Saint-Louis, Department of Pathology, Paris, France

F. Reinhart

Assistance Publique - Hopitaux de Paris, Hopital Saint-Louis, Department of Pathology, Paris, France

J. Robert

Assistance Publique - Hopitaux de Paris, Hopital Saint-Louis, DMU Biogem, Paris, France

M. Mancini

Assistance Publique - Hopitaux de Paris, Hopital Saint-Louis, Department of Pharmacology and Tumor Genomics, Paris, France

F. Herms

Assistance Publique - Hopitaux de Paris, Hopital Saint Louis, Department of Dermatology, Paris, France

B. Cribier

French Network of Rare Skin Cancers, CARADERM, Paris, France; University of Strasbourg, Dermatology and Dermatopathology, Faculty of Medicine, University Hospital, Strasbourg, France

L. Mortier

French Network of Rare Skin Cancers, CARADERM, Paris, France; Claude Huriez Hospital and University of Lille, Department of Dermatology, Lille, France

T. Jouary

French Network of Rare Skin Cancers, CARADERM, Paris, France; Hospital Center of Pau, Department of Dermatology, Pau, France

N. Basset-Seguin

Assistance Publique - Hopitaux de Paris, Hopital Saint Louis, Department of Dermatology, Paris, France

C. Lebbé

Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France; Assistance Publique - Hopitaux de Paris, Hopital Saint Louis, Department of Dermatology, Paris, France

S. Mourah

Assistance Publique - Hopitaux de Paris, Hopital Saint-Louis, Department of Pharmacology and Tumor Genomics, Paris, France; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France

M. Battistella

Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France; Assistance Publique - Hopitaux de Paris, Hopital Saint-Louis, Department of Pathology, Paris, France; French Network of Rare Skin Cancers, CARADERM, Paris, France